VGLL1 Antikörper (AA 139-250)
Kurzübersicht für VGLL1 Antikörper (AA 139-250) (ABIN7172411)
Target
Alle VGLL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 139-250
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Transcription cofactor vestigial-like protein 1 protein (139-250AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: IHC:1:200-1:500,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- VGLL1 (Vestigial Like 1 (VGLL1))
-
Andere Bezeichnung
- VGLL1
-
Hintergrund
-
Background: May act as a specific coactivator for the mammalian TEFs.
Aliases: Protein TONDU antibody, TDU antibody, TONDU antibody, Transcription cofactor vestigial like protein 1 antibody, Transcription cofactor vestigial-like protein 1 antibody, Vestigial like 1 antibody, vestigial like 1 homolog (Drosophila) antibody, Vgl-1 antibody, VGL1 antibody, Vgll1 antibody, VGLL1_HUMAN antibody
-
UniProt
- Q99990
Target
-